Antiplatelet Medications and Intracranial Hemorrhage Risk in Patients With Metastatic Brain Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors
Blood Adv 2022 Jan 27;[EPub Ahead of Print], EJ Miller, R Patell, EJ Uhlmann, S Ren, H Southard, P Elavalakanar, GM Weber, D Neuberg, JI ZwickerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.